The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.
about
Renal tumors: diagnostic and prognostic biomarkersStore-operated Ca2+ entry does not control proliferation in primary cultures of human metastatic renal cellular carcinoma.Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 casesPAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?Metastatic renal cell carcinoma: the importance of immunohistochemistry in differential diagnosis.Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer.Histologic variations and immunohistochemical features of metastatic clear cell renal cell carcinoma.Clear cell carcinoma of the base of the tongue: case report and literature review.Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas.Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition.PAX immunoreactivity in poorly differentiated small round cell tumors of childhood.Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
P2860
Q26860500-F6ECE94B-EC68-46F0-99DC-BCEBF453BF99Q33994049-4047C027-FB37-468E-8740-CFB5644F138AQ34014196-1E17096F-9B23-4AC8-BCF9-B3396896FADAQ35598471-02CE6232-F897-4C2F-94C0-0BCC47599EADQ35789475-4DE04FC9-F27A-4DA7-A147-53F295A07EC4Q36464585-2C9CB23A-A88B-46E3-A0E9-200EDF11A52FQ37316716-47FE495F-A1CD-4876-8305-2773BB36CCC2Q38229785-DF07887C-A4F7-4C6E-9351-108EFCFF6494Q43619831-312CDD72-27CA-4467-8CDE-4B4397AE3E37Q47401695-FACEFA0E-748D-43BF-8331-A2847BA91CA4Q48736924-119F7276-8055-445F-B0EF-DC8E6FDC2898Q51084111-EBA4AD06-32A9-4B3C-8EE4-3A1A8EF1F061
P2860
The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The use of immunohistochemistr ...... AX-2, hKIM-1, RCCma, and CD10.
@en
The use of immunohistochemistr ...... AX-2, hKIM-1, RCCma, and CD10.
@nl
type
label
The use of immunohistochemistr ...... AX-2, hKIM-1, RCCma, and CD10.
@en
The use of immunohistochemistr ...... AX-2, hKIM-1, RCCma, and CD10.
@nl
prefLabel
The use of immunohistochemistr ...... AX-2, hKIM-1, RCCma, and CD10.
@en
The use of immunohistochemistr ...... AX-2, hKIM-1, RCCma, and CD10.
@nl
P2093
P1476
The use of immunohistochemistr ...... AX-2, hKIM-1, RCCma, and CD10.
@en
P2093
Ankur R Sangoi
Jesse K McKenney
Reetesh K Pai
P304
P356
10.1097/PAP.0B013E3181F89400
P577
2010-11-01T00:00:00Z